Pei, X., Huang, Q., Luo, L., Sun, H., Liu, J., Sun, Y., . . . Huang, X. Letermovir prophylaxis for cytomegalovirus is associated with risk of post-transplant lymphoproliferative disorders after haploidentical stem cell transplantation. Ferrata Storti Foundation.
Chicago Style (17th ed.) CitationPei, Xu-Ying, et al. Letermovir Prophylaxis for Cytomegalovirus Is Associated with Risk of Post-transplant Lymphoproliferative Disorders After Haploidentical Stem Cell Transplantation. Ferrata Storti Foundation.
MLA (9th ed.) CitationPei, Xu-Ying, et al. Letermovir Prophylaxis for Cytomegalovirus Is Associated with Risk of Post-transplant Lymphoproliferative Disorders After Haploidentical Stem Cell Transplantation. Ferrata Storti Foundation.
Warning: These citations may not always be 100% accurate.